CTRI/2016/11/007430
Completed
未知
â??Mapping of Breast Cancer â??Transitionsâ?? to identify the Underlying Biology of Tumour Progression using Next Generation Sequencing (NGS) Technologiesâ??
SCIENCE ENGINEERING RESEARCH BOARD0 sites9 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- SCIENCE ENGINEERING RESEARCH BOARD
- Enrollment
- 9
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients just diagnosed with recurrent/metastatic breast cancer after a previous diagnosis and treatment of non\-metastatic breast cancer OR de nevo metastatic breast cancer
- •Patients whose primary tumors are stored in the Tumor Tissue Repository of Tata Memorial Hospital in liquid nitrogen
- •Patients willing to provide written informed consent to participate in the study including biopsies from recurrent/metastatic sites and longitudinal follow\-up in their metastatic course
- •Patients in whom biopsy from recurrent/metastatic sites can be performed with reasonable safety
- •Patients whose tumors are triple negative by IHC (ER\-/PR\-/HER2\-)
- •Patients willing to receive the usual standard treatment for metastatic breast cancer
Exclusion Criteria
- •No exclusion criteria
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Tumor differentiation in breast carcinomas with a novel physical methodC50Malignant neoplasm of breastDRKS00012767Department für Frauengesundheit150
Completed
Not Applicable
Visualization of breast cancer with the first generation photoacoustic mammoscopebreast cancercarcinoma of the breast10006291NL-OMON39181niversiteit Twente73
Completed
Not Applicable
Whole-body staging in breast cancer patients using combined MR-PETC50Malignant neoplasm of breastDRKS00005410niversitätsklinikum Düsseldorf, Institut für Diagnostische und Interventionelle Radiologie276
Unknown
Not Applicable
PIVOTAL STUDY IN PATIENTS WITH BREAST CANCER TO INVESTIGATE THE EFFICACY AND SAFETY OF LA-EP2006 and NEULASTA ®PER-119-11Sandoz GmbH,
Completed
Not Applicable
Breast cancer subtype and distant recurrences after ipsilateral breast tumor recurrencesJPRN-UMIN000008136Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society300